Subscribe to RSS
Targeted Renal Biopsy: Predictors on Imaging
Objectives The renal nephrometry score uses imaging characteristics such as lesion diameter, location, and proximity to hilar vessels to categorize renal masses by complexity for preoperative planning. These characteristics may also be used to determine the best approach to targeted renal biopsy. This study was conducted to investigate the impact of renal lesion characteristics as measured by the renal nephrometry score on the choice of modality used for performing a targeted renal lesion biopsy and increasing the chance of yielding a diagnostic biopsy.
Materials and Methods All targeted computed tomography (CT)/ultrasound-guided renal biopsies performed by our radiology department from January 2017 to February 2020 were reviewed. Radiological characteristics and pathological outcomes were recorded with data on lesion size/ side, location in craniocaudal/anterior–posterior planes, endophytic/exophytic/mixed nature, and skin-lesion distance.
Statistical Analysis Chi-squared tests, multivariate analysis, and t-tests were used in this study.
Results Of the 145 consecutive patients included in the study, 86.2% (125/145) biopsies were diagnostic. About 54.5% (79/145) biopsies were ultrasound-guided, while 45.5% (66/145) were CT-guided. About 62.1% (90/145) biopsies revealed renal cell carcinoma. The highest rate of diagnostic biopsy was in the exophytic, laterally positioned mass either entirely below lower polar or above upper polar line. Ultrasound was preferred for lesions under 4cm and 4 to 7cm (p = 0.06). CT was used for anterior lesions and ultrasound for posterior and lateral lesions (p < 0.001). Of the 20 nondiagnostic biopsies, 7/20 had a repeat biopsy, 7/20 underwent surveillance, 5/20 underwent partial or total nephrectomy, and 1/20 underwent a pathological lymph node biopsy.
Conclusions Our study highlights some factors radiologists should consider when predicting whether CT or ultrasound guidance is more appropriate and the probability of achieving a diagnostic biopsy based on lesion characteristics. At our institution, both modalities achieved high accuracy, although we favored ultrasound in lateral, posterior, and small lesions. These factors should be weighed against local experience and preference.
Article published online:
14 November 2022
© 2022. The Pan Arab Interventional Radiology Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170 (6 Pt 1): 2217-2220
- 2 Parsons RB, Canter D, Kutikov A, Uzzo RG. RENAL nephrometry scoring system: the radiologist's perspective. AJR Am J Roentgenol 2012; 199 (03) W355-9
- 3 Sahni VA, Silverman SG. Biopsy of renal masses: when and why. Cancer Imaging 2009; 9: 44-55
- 4 Uppot RN, Harisinghani MG, Gervais DA. Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol 2010; 194 (06) 1443-1449
- 5 Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991; 179 (02) 307-317
- 6 Canter D, Kutikov A, Manley B. et al. Utility of the RENAL-nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011; 78: 1089-1094
- 7 Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182 (03) 844-853
- 8 Millet I, Doyon FC, Hoa D. et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT?. AJR Am J Roentgenol 2011; 197 (04) 887-896
- 9 Wang R, Li AY, Wood Jr DP. The role of percutaneous renal biopsy in the management of small renal masses. Curr Urol Rep 2011; 12 (01) 18-23
- 10 Thompson RH, Hill JR, Babayev Y. et al. Metastatic renal cell carcinoma risk according to tumor size. J Urol 2009; 182 (01) 41-45
- 11 Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol 2007; 177 (05) 1692-1696 , discussion 1697